
Parex LPD 325 Tablets
Parex LPD 325 Tablets are a multi-symptom relief formula designed to alleviate cold, allergy, and flu symptoms effectively. Each tablet contains a scientifically balanced combination of:
- Paracetamol 325 mg – Provides fast-acting pain relief and fever reduction.
- Levocetirizine Dihydrochloride 5 mg – A potent antihistamine that relieves sneezing, runny nose, and itchy eyes.
- Dextromethorphan HBr 5 mg – Suppresses dry, irritating cough by acting on the brain’s cough center.
- Phenylephrine Hydrochloride 5 mg – A nasal decongestant that eases blocked sinuses and improves airflow.
- Caffeine (Anhydrous) 30 mg – Enhances the pain-relieving effect of paracetamol and reduces drowsiness.
Pharmacokinetics and Pharmacodynamics
- Paracetamol: Quickly absorbed; metabolized in the liver with analgesic and antipyretic action.
- Levocetirizine: Rapidly absorbed; blocks histamine H1 receptors, easing allergy symptoms.
- Dextromethorphan: Centrally suppresses the cough reflex through action on the medulla.
- Phenylephrine: Acts on alpha-adrenergic receptors to relieve nasal congestion.
- Caffeine: Stimulates the central nervous system and enhances the effect of paracetamol.
Dosage Information
- Adults: 1 tablet every 6–8 hours as needed.
- Maximum Daily Dose: Do not exceed 4 tablets in 24 hours.
- Always follow physician’s advice for dosage and duration.
Contraindications
- Known hypersensitivity to any component.
- Severe hepatic or renal impairment.
- Use of monoamine oxidase inhibitors (MAOIs) or other CNS depressants.
- Not recommended during pregnancy or breastfeeding without medical supervision.
Storage
- Store below 30°C in a dry place.
- Keep away from light and moisture.
- Keep out of reach of children.
Warnings and Precautions
- Avoid alcohol while taking this medication.
- Use with caution in patients with hypertension, diabetes, thyroid disorders, or glaucoma.
- Stop use and consult a healthcare professional if symptoms persist or worsen.
- Not intended for long-term use without medical guidance.